125 related articles for article (PubMed ID: 38415545)
21. Treatment volume from total reference air kerma (TRAK) in intracavitory applications and its comparison with ICRU reference volume.
Deshpande DD; Shrivastava SK; Nehru RM; Viswanathan PS; Dinshaw KA
Int J Radiat Oncol Biol Phys; 1994 Jan; 28(2):499-504. PubMed ID: 8276667
[TBL] [Abstract][Full Text] [Related]
22. Impact of 3D image-based PDR brachytherapy on outcome of patients treated for cervix carcinoma in France: results of the French STIC prospective study.
Charra-Brunaud C; Harter V; Delannes M; Haie-Meder C; Quetin P; Kerr C; Castelain B; Thomas L; Peiffert D
Radiother Oncol; 2012 Jun; 103(3):305-13. PubMed ID: 22633469
[TBL] [Abstract][Full Text] [Related]
23. Interfraction variations in doses at OARs during three-dimensional high dose rate brachytherapy planning of cervix cancer.
Dhaka S; Rajani A; Kumar HS; Sharma N; Jakhar SL; Harsh K
J Cancer Res Ther; 2023; 19(5):1136-1141. PubMed ID: 37787275
[TBL] [Abstract][Full Text] [Related]
24. Patterns of brachytherapy practice for patients with carcinoma of the cervix (1996-1999): a patterns of care study.
Erickson B; Eifel P; Moughan J; Rownd J; Iarocci T; Owen J
Int J Radiat Oncol Biol Phys; 2005 Nov; 63(4):1083-92. PubMed ID: 16099599
[TBL] [Abstract][Full Text] [Related]
25. Duplicating a tandem and ovoids distribution with intensity-modulated radiotherapy: a feasibility study.
Malhotra HK; Avadhani JS; de Boer SF; Jaggernauth W; Kuettel MR; Podgorsak MB
J Appl Clin Med Phys; 2007 Jul; 8(3):91-98. PubMed ID: 17712303
[TBL] [Abstract][Full Text] [Related]
26. A comparison between revised Manchester Point A and ICRU-89-recommended Point A definition absorbed-dose reporting using CT images in intracavitary brachytherapy for patients with cervical carcinoma.
Mourya A; Choudhary S; Shahi UP; Sharma N; Gautam H; Patel G; Pradhan S; Aggarwal LM
Brachytherapy; 2021; 20(1):118-127. PubMed ID: 32811759
[TBL] [Abstract][Full Text] [Related]
27. Using the computed tomography in comparison to the orthogonal radiography based treatment planning in high dose rate (HDR) brachytherapy in cervical uteri cancer patients; a single institution feasibility study.
Bahadur YA; El-Sayed ME; El-Taher ZH; Zaza KO; Moftah BA; Hassouna AH; Ghassal NM
J Egypt Natl Canc Inst; 2008 Mar; 20(1):1-9. PubMed ID: 19847276
[TBL] [Abstract][Full Text] [Related]
28. A patient-based dosimetric study of intracavitary and interstitial brachytherapy in advanced stage carcinoma of the cervix.
Bansal AK; Semwal MK; Sharma DN; Thulkar S; Julka PK; Rath GK
J Appl Clin Med Phys; 2014 May; 15(3):4509. PubMed ID: 24892331
[TBL] [Abstract][Full Text] [Related]
29. A dosimetric comparison between applicators used for brachytherapy in carcinoma cervix - A single-institute prospective study.
Suryadevara A; Kumar MV; Vasundhara E; Alluri KR; Ahamed S; Guduru S
Indian J Cancer; 2018; 55(3):230-232. PubMed ID: 30693884
[TBL] [Abstract][Full Text] [Related]
30. Commissioning of a 3D image-based treatment planning system for high-dose-rate brachytherapy of cervical cancer.
Kim Y; Modrick JM; Pennington EC; Kim Y
J Appl Clin Med Phys; 2016 Mar; 17(2):405-426. PubMed ID: 27074463
[TBL] [Abstract][Full Text] [Related]
31. Comparison between CT-based volumetric calculations and ICRU reference-point estimates of radiation doses delivered to bladder and rectum during intracavitary radiotherapy for cervical cancer.
Pelloski CE; Palmer M; Chronowski GM; Jhingran A; Horton J; Eifel PJ
Int J Radiat Oncol Biol Phys; 2005 May; 62(1):131-7. PubMed ID: 15850913
[TBL] [Abstract][Full Text] [Related]
32. Conventional conformal radiotherapy vs intracavitary brachytherapy for the adjuvant postoperative treatment of cervical cancer: a comparative dosimetric study.
Milosević NT; Dabić-Stanković KM; Stanković JB; Mileusnić DS
Acta Chir Iugosl; 2009; 56(4):189-94. PubMed ID: 20420019
[TBL] [Abstract][Full Text] [Related]
33. Comparison of 2D vs. 3D dosimetry for Rotte 'Y' applicator high dose rate brachytherapy for medically inoperable endometrial cancer.
Beriwal S; Kim H; Heron DE; Selvaraj R
Technol Cancer Res Treat; 2006 Oct; 5(5):521-7. PubMed ID: 16981795
[TBL] [Abstract][Full Text] [Related]
34. Dynamics of High Risk Clinical Target Volume reduction during Brachytherapy and impact on its coverage in patients with inoperable cervical cancer.
Pobijakova M; Scepanovic D; Paluga M; Fekete M; Mardiak J
Neoplasma; 2018 Mar; 65(3):425-430. PubMed ID: 29788726
[TBL] [Abstract][Full Text] [Related]
35. Preliminary results of conformal computed tomography (CT)-based intracavitary brachytherapy (ICBT) for locally advanced cervical cancer: a single institution's experience.
Tharavichitkul E; Mayurasakorn S; Lorvidhaya V; Sukthomya V; Wanwilairat S; Lookaew S; Pukanhaphan N; Chitapanarux I; Galalae R
J Radiat Res; 2011; 52(5):634-40. PubMed ID: 21952319
[TBL] [Abstract][Full Text] [Related]
36. Comparison of conventional and CT-based planning for intracavitary brachytherapy for cervical cancer: target volume coverage and organs at risk doses.
Onal C; Arslan G; Topkan E; Pehlivan B; Yavuz M; Oymak E; Yavuz A
J Exp Clin Cancer Res; 2009 Jul; 28(1):95. PubMed ID: 19570212
[TBL] [Abstract][Full Text] [Related]
37. Feasibility of applying a single treatment plan for both fractions in PDR image guided brachytherapy in cervix cancer.
Mohamed S; Nielsen SK; Fokdal LU; Pedersen EM; Lindegaard JC; Tanderup K
Radiother Oncol; 2013 Apr; 107(1):32-8. PubMed ID: 23333020
[TBL] [Abstract][Full Text] [Related]
38. Dosimetric comparison of various optimization techniques for high dose rate brachytherapy of interstitial cervix implants.
Shwetha B; Ravikumar M; Katke A; Supe SS; Venkatagiri G; Ramanand N; Pasha T
J Appl Clin Med Phys; 2010 Jul; 11(3):3227. PubMed ID: 20717091
[TBL] [Abstract][Full Text] [Related]
39. Adaptive brachytherapy treatment planning for cervical cancer using FDG-PET.
Lin LL; Mutic S; Low DA; LaForest R; Vicic M; Zoberi I; Miller TR; Grigsby PW
Int J Radiat Oncol Biol Phys; 2007 Jan; 67(1):91-6. PubMed ID: 17189066
[TBL] [Abstract][Full Text] [Related]
40. The population percentile allowance method for determining systematic spatial error tolerances for temporary intensity modulated brachytherapy.
Hopfensperger KM; Adams QE; Kim Y; Wu X; Xu W; Patwardhan K; Flynn RT
Med Phys; 2023 Oct; 50(10):6469-6478. PubMed ID: 37643427
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
